FDA Inspection 1211289 — New York Presbyterian Hospital Weill Cornell Medical College

New York Presbyterian Hospital Weill Cornell Medical College — FEI 3003972369

The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on July 25, 2023 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 25, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)